tm logo
L
Dead/Abandoned
ABANDONED - AFTER INTER-PARTES DECISION

after inter

on 27 Jan 2018

Last Applicant/ Owned by

Che Gong Miao, No. 6009 Shennan Road,

Futian Dist. Shenzhen

CN

518040

Serial Number

87425805 filed on 26th Apr 2017

Registration Number

N/A

Correspondent Address

Timothy T. Wang

TIMOTHY T WANG

8140 WALNUT HILL LANE SUITE 500

DALLAS, TX 75231

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

L

Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system a Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases

Mark Details


Serial Number

No 87425805

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.15.03 -

Incomplete polygons and polygons made of broken or dotted lines

26.15.28 -

Miscellaneous designs with overall polygon shape

26.19.04 -

Cubes

27.01.04 -

Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps

Legal History


Show more

Status DateAction Taken
29th Jan 2018ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
27th Jan 2018OPPOSITION TERMINATED NO. 999999
27th Jan 2018ABANDONMENT - AFTER INTER PARTES DECISION
27th Jan 2018OPPOSITION SUSTAINED NO. 999999
19th Oct 2017OPPOSITION INSTITUTED NO. 999999
19th Oct 2017OPPOSITION PAPERS RECEIVED AT TTAB
19th Sep 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19th Sep 2017PUBLISHED FOR OPPOSITION
30th Aug 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27th Jul 2017APPROVED FOR PUB - PRINCIPAL REGISTER